Hypercoagulability in cancer (Q41033291)

25 September 2017

1 reference

title

Hypercoagulability in cancer (English)

1 reference

25 September 2017

1 reference

Green KB

1

1 reference

PubMed ID

8707766

25 September 2017

Silverstein RL

series ordinal

2

1 reference

25 September 2017

1 April 1996

1 reference

Hematology / Oncology Clinics of North America

25 September 2017

1 reference

25 September 2017

10

1 reference

25 September 2017

2

1 reference

25 September 2017

499-530

1 reference

Idiopathic deep vein thrombosis in an apparently healthy patient as a premonitory sign of occult cancer

25 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Cancer procoagulant in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Effects of tamoxifen on blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Trousseau's syndrome. Devastating coagulopathy in the absence of heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Mutation in blood coagulation factor V associated with resistance to activated protein C.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Spiral-computed tomography versus pulmonary angiography in the diagnosis of acute massive pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

HLA-DR is a procoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Greenfield filter instead of heparin as primary treatment for deep venous thrombosis or pulmonary embolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: prediction of a cofactor to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Vascular toxicity associated with antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Tumor shedding and coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Regulation of extravascular coagulation by microvascular permeability.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Complications of indwelling venous access devices in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Tamoxifen treatment of metastatic breast cancer and antithrombin III levels

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The regulation of natural anticoagulant pathways.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

1992 ARRS Executive Council Award. Detection of deep venous thrombosis: prospective comparison of MR imaging with contrast venography.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The hypercoagulable state in cancer patients: evidence for impaired thrombin inhibitions

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Acquired protein C deficiency in patients with breast cancer receiving cyclophosphamide, methotrexate, and 5-fluorouracil

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

A randomized clinical trial evaluating tamoxifen in the treatment of patients with node-negative breast cancer who have estrogen-receptor-positive tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Local infusion of urokinase for the lysis of thrombosis associated with permanent central venous catheters in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Molecular and cellular biology of blood coagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Role of plasma, platelets, and endothelial cells in tumor metastasis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Increased incidence of thromboembolism in stage IV breast cancer patients treated with a five-drug chemotherapy regimen. A study of 159 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Cancer procoagulant A: A factor X activating procoagulant from malignant tissue

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Occult cancer in patients with acute pulmonary embolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Hypercoagulability during L-asparaginase treatment: the effect of antithrombin III supplementation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Clinical and Therapeutic Considerations in Nonbacterial Thrombotic Endocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Serial impedance plethysmography for suspected deep venous thrombosis in outpatients. The Amsterdam General Practitioner Study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Diagnostic efficacy of impedance plethysmography for clinically suspected deep-vein thrombosis. A randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Diagnostic value of ventilation-perfusion lung scanning in patients with suspected pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Pulmonary angiography, ventilation lung scanning, and venography for clinically suspected pulmonary embolism with abnormal perfusion lung scan

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Erythromelalgia and myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Subclavian vein thrombosis in patients treated with infusion chemotherapy for advanced malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Complications and management of implanted venous access catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Alterations of factor VIII von Willebrand factor in clinical conditions associated with an increase in its plasma concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Fibrinogen kinetics in patients with neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Thromboregulation: multicellular modulation of platelet reactivity in hemostasis and thrombosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Mucin-producing adenocarcinomas and nonbacterial thrombotic endocarditis: pathogenetic role of tumor mucin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Budd-Chiari syndrome: etiology, diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Abnormalities of PIG-A transcripts in granulocytes from patients with paroxysmal nocturnal hemoglobinuria

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Occult cancer in patients with deep venous thrombosis. A systematic approach

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Is embolic risk conditioned by location of deep venous thrombosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Hypercoagulable states

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Hemostatic abnormalities in untreated cancer: incidence and correlation with thrombotic and hemorrhagic complications

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Cachexia and the acute-phase protein response in inflammation are regulated by interleukin-6

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Occlusion of the hepatic veins in man

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Vascular occlusive episodes and venous haematocrit in primary proliferative polycythaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Superior vena cava thrombosis related to catheter malposition in cancer chemotherapy given through implanted ports

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

A syndrome of thrombosis and hemorrhage complicating L-asparaginase therapy for childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The effect of L-asparaginase on antithrombin, plasminogen, and plasma coagulation during therapy for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Altered von Willebrand factor molecule in children with thrombosis following asparaginase-prednisone-vincristine therapy for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Involvement of von Willebrand factor in thrombosis following asparaginase-prednisone-vincristine therapy for leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The relationship between the thrombotic and infectious complications of central venous catheters

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Tissue factor as a tumor procoagulant

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique--comparison with pulmonary angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Chemotherapy for breast cancer decreases plasma protein C and protein S.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Venous and arterial thrombosis in patients who received adjuvant therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Hypercoagulable states: molecular genetics to clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Diagnosis and treatment of recurrent venous thromboembolism

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Use of percutaneously inserted venous catheters in coronary care units

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Hemostatic Abnormalities in Malignancy, a Prospective Study of One Hundred Eight Patients: Part I. Coagulation Studies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

von Willebrand factor in head and neck cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Protein C and S levels in acute leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Studies on the pathogenesis of coagulopathy in patients with arterial thromboembolism and malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Etiology of portal vein thrombosis in adults. A prospective evaluation of primary myeloproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Primary myeloproliferative disorder and hepatic vein thrombosis. A prospective study of erythroid colony formation in vitro in 20 patients with Budd-Chiari syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Antithrombin III depression and thrombin generation acceleration in women taking oral contraceptives

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Diagnosis of deep-vein thrombosis using duplex ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

The pathogenesis and treatment of thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Clinical trials with anticoagulant and antiplatelet therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

Pathways of coagulation/fibrinolysis activation in malignancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8588%2805%2970349-X

7 January 2021

10.1016/S0889-8588(05)70349-X

Identifiers

DOI

1 reference

25 September 2017

1 reference

PubMed ID

8707766